You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
MGI hopes to ship the sequencer, one of several products it unveiled at the International Conference on Genomics, to early-access partners in early 2020.
Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.
Ginkgo plans to strategically partner with leading companies in mature markets to create synthetic biology-based spinouts, something it has already done in ag-bio.
UgenTec's FastFinder software platform uses artificial intelligence to enable analysis and interpretation of qPCR data, workflow automation, and genotyping.
The company was founded by Washington State University scientists to offer molecular breeding and genomic services for cannabis cultivation.
The San Diego-based DNA synthesis firm this week announced $12.2 million in Series A funding, but has plans to expand the round.
Ginkgo will acquire Beacon optofluidic platforms from Berkeley Lights and incorporate them into its automated genetic engineering foundries.
The firm will use the funding to advance its enzymatic DNA synthesis technology, which has applications in life sciences, information storage, synthetic biology, and electronics.
The firm will use the funds to continue expanding its technology into food and agriculture testing, in addition to growing its cannabis testing business.
The Boston-based synthetic biology firm said it will use the funds to grow its cell programing platform, which it will make available to startups.
The firms have developed a cannabis sequencing panel, called myBaits MGC Cannabis Panel, which they will be offering for sequencing service work.
The synthetic biology and DNA data storage firm will use the funds to launch its BioXp 3200 automated gene synthesis and cloning platform.
CFSRE recently validated Verogen's NGS-based forensics platform and will develop implementation and training materials for law enforcement.
The Genome Sensor — the first product Cardea will market under the Nanosens brand — will allow the user to Google a genome using a single guide RNA.
The French metagenomic sequencing firm received funding from both historical and new investors, including debt financing from Norgine Ventures.
The technology uses a proprietary chemistry that attaches primers to probes with a polyethylene glycol-based linker to prevent the formation of primer-dimers.
The projects are focused on the impact of microbe communities on soil nutrient cycling, and the relationship between gene function and beneficial plant traits.
The five-year project aims to analyze environmental DNA in three Maine watersheds to improve the management of the state's coastal ecosystems.
Built on concepts developed in Timothy Lu's MIT lab, a new approach to DNA-based computing in a cell increases precision and, potentially, scale.
The $10 million initiative will include scientists from the University of California's campuses, as well as from governmental and nongovernmental organizations.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.